• Mark Watson-Mitchell

Moore Stephens sees recovery

Early signs of recovery as the deal volumes increase significantly is the anticipation of Moore Kingston Smith Corporate Finance.





The Coronavirus Future Fund has provided a major boost to the UK growth capital market, and we have seen deal activity increase by 28% in Q3 2020.


Businesses with scalable software and technology solutions continued to be popular with investors as did biotechnology and healthcare companies.


The extension of the Future Fund into Q4 and beyond creates an extremely benign environment for those seeking capital to fund their further expansion.

Recent Posts

See All

The asset class suffered another torrid month with small and mid-cap equities once more bearing the brunt of the losses, although large cap indices did suffer to a moderate extent. The concerning dou

By Frédérique Carrier, Head of Investment Strategy in the British Isles and Asia at RBC Wealth Management Long dry spells and retreating water levels are exposing many finds from forgotten archaeologi

£3m in new equity raised London’s Alternative Investment Market experienced its lowest number of initial public offerings for one quarter in 13 years in Q3 2022, with just one company listing. Resea